Allina Health System
Allina Health System was paid $1.07M by Medicaid between Jan 2018 and Nov 2024, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
COON RAPIDS, MN 55433
Next to other Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,056 | $51K | |
| 2019 | 8,109 | $142K | |
| 2020 | 9,336 | $188K | |
| 2021 | 10,175 | $319K | |
| 2022 | 7,248 | $214K | |
| 2023 | 3,110 | $92K | |
| 2024incomplete | 1,944 | $63K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 4,899 | 4,335 | $238K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 12% | 124 | 123 | $123K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.1% | 1,073 | 1,017 | $65K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.0% | 2,259 | 2,188 | $64K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 5.9% | 952 | 926 | $63K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.8% | 2,199 | 2,129 | $62K |
| 36415 | Collection of venous blood by venipuncture | 3.8% | 12,155 | 10,650 | $40K |
| 86780 | 3.2% | 2,855 | 2,802 | $35K | |
| 81514 | 2.9% | 119 | 118 | $31K | |
| 87481 | 2.7% | 910 | 884 | $29K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.6% | 944 | 904 | $27K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.4% | 832 | 809 | $26K |
48 more codes
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 2.3% | 1,094 | $24K |
| 59025 | Fetal non-stress test | 2.2% | 1,387 | $24K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.1% | 316 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.7% | 861 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 1,515 | $16K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 1.5% | 1,263 | $16K |
| 87150 | 1.3% | 403 | $14K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.3% | 172 | $14K |
| 86803 | 1.2% | 1,008 | $13K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 204 | $11K |
| 90715 | <1% | 399 | $10K | |
| 90686 | <1% | 545 | $8K | |
| 81025 | <1% | 1,012 | $7K | |
| 87340 | <1% | 832 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 66 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 51 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 829 | $5K |
| 85018 | <1% | 2,015 | $4K | |
| 87210 | <1% | 1,034 | $4K | |
| 82950 | <1% | 945 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 48 | $4K |
| 86850 | <1% | 572 | $4K | |
| 85027 | <1% | 584 | $3K | |
| 76801 | <1% | 39 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 38 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 211 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 43 | $2K |
| 86787 | <1% | 267 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 46 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 20 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 48 | $1K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $968.90 |
| 87081 | <1% | 197 | $892.12 | |
| 58300 | <1% | 14 | $853.24 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 80 | $769.84 |
| 84702 | <1% | 69 | $735.14 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $718.34 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 23 | $601.42 |
| 82728 | <1% | 27 | $219.66 | |
| 99000 | <1% | 147 | $186.69 | |
| 80061 | Lipid panel | <1% | 29 | $159.86 |
| 81001 | <1% | 32 | $103.91 | |
| 82947 | <1% | 24 | $52.18 | |
| 86901 | <1% | 28 | $47.40 | |
| 86900 | <1% | 28 | $47.40 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29 | $9.96 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 25 | $0.00 |
| 86762 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.